[Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo].
Pure red cell aplasia (PRCA) is a rare condition described in patients with chronic kidney disease during alpha-Epo treatment subcutaneous administered generated by anti-R-Epo antibodies. Recently two cases of PRCA have been reported in patients affected by myelodysplastic syndrome treated with R-Epo. We described one more case of PRCA in a patient with refractory anemia treated with R-Epo.
Luraschi
Annalisa
A
UOA di Oncologia Medica, Regione Piemonte ASL VCO, Ospedale, Verbania.
Montanara
Sergio
S
Fedeli
Paola
P
Buscaglia
Paola
P
Fossati
Ornella
O
Cozzi
Sergio
S
Castello
Alessandro
A
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D001803:Blood Transfusion; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000628:therapy; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D011994:Recombinant Proteins; D004921:Erythropoietin